These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14599340)

  • 1. Redox properties of myeloperoxidase.
    Arnhold J; Furtmüller PG; Obinger C
    Redox Rep; 2003; 8(4):179-86. PubMed ID: 14599340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase.
    Furtmüller PG; Arnhold J; Jantschko W; Pichler H; Obinger C
    Biochem Biophys Res Commun; 2003 Feb; 301(2):551-7. PubMed ID: 12565898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of oxygen binding to ferrous myeloperoxidase.
    Jantschko W; Furtmüller PG; Zederbauer M; Jakopitsch C; Obinger C
    Arch Biochem Biophys; 2004 Jun; 426(1):91-7. PubMed ID: 15130787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard reduction potentials of all couples of the peroxidase cycle of lactoperoxidase.
    Furtmüller PG; Arnhold J; Jantschko W; Zederbauer M; Jakopitsch C; Obinger C
    J Inorg Biochem; 2005 May; 99(5):1220-9. PubMed ID: 15833345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design.
    Jantschko W; Furtmüller PG; Zederbauer M; Neugschwandtner K; Lehner I; Jakopitsch C; Arnhold J; Obinger C
    Biochem Pharmacol; 2005 Apr; 69(8):1149-57. PubMed ID: 15794935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the covalent glutamic acid 242-heme linkage in the formation and reactivity of redox intermediates of human myeloperoxidase.
    Zederbauer M; Jantschko W; Neugschwandtner K; Jakopitsch C; Moguilevsky N; Obinger C; Furtmüller PG
    Biochemistry; 2005 May; 44(17):6482-91. PubMed ID: 15850382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of interconversion of redox intermediates of lactoperoxidase, eosinophil peroxidase and myeloperoxidase.
    Furtmüller PG; Jantschko W; Zederbauer M; Jakopitsch C; Arnhold J; Obinger C
    Jpn J Infect Dis; 2004 Oct; 57(5):S30-1. PubMed ID: 15507766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DFT calculations suggest a new type of self-protection and self-inhibition mechanism in the mammalian heme enzyme myeloperoxidase: nucleophilic addition of a functional water rather than one-electron reduction.
    Sicking W; Somnitz H; Schmuck C
    Chemistry; 2012 Aug; 18(35):10937-48. PubMed ID: 22829409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox properties of the couple compound I/native enzyme of myeloperoxidase and eosinophil peroxidase.
    Arnhold J; Furtmüller PG; Regelsberger G; Obinger C
    Eur J Biochem; 2001 Oct; 268(19):5142-8. PubMed ID: 11589706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxynitrite efficiently mediates the interconversion of redox intermediates of myeloperoxidase.
    Furtmüller PG; Jantschko W; Zederbauer M; Schwanninger M; Jakopitsch C; Herold S; Koppenol WH; Obinger C
    Biochem Biophys Res Commun; 2005 Nov; 337(3):944-54. PubMed ID: 16214107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
    Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
    J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the binding and reactivity of plant and mammalian peroxidases to indole derivatives by computational docking.
    Hallingbäck HR; Gabdoulline RR; Wade RC
    Biochemistry; 2006 Mar; 45(9):2940-50. PubMed ID: 16503648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid.
    Allegra M; Furtmüller PG; Jantschko W; Zederbauer M; Tesoriere L; Livrea MA; Obinger C
    Biochem Biophys Res Commun; 2005 Jul; 332(3):837-44. PubMed ID: 15913556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox thermodynamics of the Fe(III)/Fe(II) couple of human myeloperoxidase in its high-spin and low-spin forms.
    Battistuzzi G; Bellei M; Zederbauer M; Furtmüller PG; Sola M; Obinger C
    Biochemistry; 2006 Oct; 45(42):12750-5. PubMed ID: 17042493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.
    Aldib I; Gelbcke M; Soubhye J; Prévost M; Furtmüller PG; Obinger C; Elfving B; Alard IC; Roos G; Delporte C; Berger G; Dufour D; Zouaoui Boudjeltia K; Nève J; Dufrasne F; Van Antwerpen P
    Eur J Med Chem; 2016 Nov; 123():746-762. PubMed ID: 27537923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids as promoters of the (pseudo-)halogenating activity of lactoperoxidase and myeloperoxidase.
    Gau J; Furtmüller PG; Obinger C; Prévost M; Van Antwerpen P; Arnhold J; Flemmig J
    Free Radic Biol Med; 2016 Aug; 97():307-319. PubMed ID: 27350402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase-catalyzed taurine chlorination: initial versus equilibrium rate.
    Ramos DR; Victoria García M; Canle L M; Arturo Santaballa J; Furtmüller PG; Obinger C
    Arch Biochem Biophys; 2007 Oct; 466(2):221-33. PubMed ID: 17868637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox properties of heme peroxidases.
    Battistuzzi G; Bellei M; Bortolotti CA; Sola M
    Arch Biochem Biophys; 2010 Aug; 500(1):21-36. PubMed ID: 20211593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic evidence for rapid oxidation of (-)-epicatechin by human myeloperoxidase.
    Spalteholz H; Furtmüller PG; Jakopitsch C; Obinger C; Schewe T; Sies H; Arnhold J
    Biochem Biophys Res Commun; 2008 Jul; 371(4):810-3. PubMed ID: 18466756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.
    Soubhye J; Prévost M; Van Antwerpen P; Zouaoui Boudjeltia K; Rousseau A; Furtmüller PG; Obinger C; Vanhaeverbeek M; Ducobu J; Néve J; Gelbcke M; Dufrasne FO
    J Med Chem; 2010 Dec; 53(24):8747-59. PubMed ID: 21090682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.